126 related articles for article (PubMed ID: 1505405)
1. Experience with carbimazole in the drug treatment of the hyperthyroidism of Graves' diseases in Nigerians.
Modebe O
East Afr Med J; 1992 Mar; 69(3):153-6. PubMed ID: 1505405
[TBL] [Abstract][Full Text] [Related]
2. Experience with carbimazole in the treatment of the hyperthyroidism of Graves' disease in Nigerian patients.
Modebe O
Afr J Med Med Sci; 1995 Dec; 24(4):347-51. PubMed ID: 8886149
[TBL] [Abstract][Full Text] [Related]
3. Once daily, low dose, short term antithyroid drug treatment of Graves' disease is followed by an unacceptably high relapse rate.
Ford HC; Feek CM; Delahunt JW
N Z Med J; 1991 Mar; 104(907):97-8. PubMed ID: 2006072
[TBL] [Abstract][Full Text] [Related]
4. Remission of Graves' hyperthyroidism treated with methimazole.
Bolaños F; González-Ortiz M; Durón H; Sánchez C
Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
6. Prediction of outcome in Graves' disease after carbimazole treatment.
Weetman AP; Ratanachaiyavong S; Middleton GW; Love W; John R; Owen GM; Darke C; Lazarus JH; Hall R; McGregor AM
Q J Med; 1986 Apr; 59(228):409-19. PubMed ID: 2875484
[TBL] [Abstract][Full Text] [Related]
7. Prediction of remission after antithyroid drug treatment in Graves' disease.
Young ET; Steel NR; Taylor JJ; Stephenson AM; Stratton A; Holcombe M; Kendall-Taylor P
Q J Med; 1988 Feb; 66(250):175-89. PubMed ID: 2902655
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Graves' disease with the block-replace regimen of antithyroid drugs: the effect of treatment duration and immunogenetic susceptibility on relapse.
Weetman AP; Pickerill AP; Watson P; Chatterjee VK; Edwards OM
Q J Med; 1994 Jun; 87(6):337-41. PubMed ID: 7913766
[TBL] [Abstract][Full Text] [Related]
9. [Recurrence of Graves-Basedow disease: the influence of treatment schedule].
Goñi Iriarte MJ; Forga Llenas L; Iriarte Beroiz A; Apiñániz EA; Rodríguez Erdozain R; Menéndez Torre E
Med Clin (Barc); 1995 Jan; 104(1):11-4. PubMed ID: 7877347
[TBL] [Abstract][Full Text] [Related]
10. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
El Refaei SM; Shawkat W
Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
[TBL] [Abstract][Full Text] [Related]
11. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease.
Schott M; Morgenthaler NG; Fritzen R; Feldkamp J; Willenberg HS; Scherbaum WA; Seissler J
Horm Metab Res; 2004 Feb; 36(2):92-6. PubMed ID: 15002058
[TBL] [Abstract][Full Text] [Related]
12. [Carbimazole therapy in Basedow's disease: therapy results in individual dosage adjustment].
Trabucco P; Engler H; Ryff-de Lèche A; Althaus B; Staub JJ
Schweiz Med Wochenschr; 1989 Dec; 119(52):1894-8. PubMed ID: 2609144
[TBL] [Abstract][Full Text] [Related]
13. Juvenile thyrotoxicosis--a South Island, New Zealand experience with long-term outcome.
Brownlie BE; Hunt PJ; Turner JG
N Z Med J; 2010 Apr; 123(1313):23-31. PubMed ID: 20581892
[TBL] [Abstract][Full Text] [Related]
14. Relapse after short-term antithyroid therapy of Graves' disease.
Burr WA; Fitzgerald MG; Hoffenberg R
N Engl J Med; 1979 Jan; 300(4):200. PubMed ID: 581607
[No Abstract] [Full Text] [Related]
15. Remission with carbimazole therapy & assessment of T4 suppression test as an index of relapse in patients with Graves' disease in India.
Goswami R; Bal CS; Gupta N; Kochupillai N
Indian J Med Res; 1996 May; 103():272-7. PubMed ID: 8707364
[TBL] [Abstract][Full Text] [Related]
16. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
[TBL] [Abstract][Full Text] [Related]
17. Juvenile hyperthyroidism: an experience.
Bhadada S; Bhansali A; Velayutham P; Masoodi SR
Indian Pediatr; 2006 Apr; 43(4):301-7. PubMed ID: 16651668
[TBL] [Abstract][Full Text] [Related]
18. [Prospective study on the relationship between treatment duration of antithyroid drug and remission rate of Graves' disease].
Liu C; Duan Y; Wu X
Zhonghua Yi Xue Za Zhi; 2000 Nov; 80(11):835-7. PubMed ID: 11218878
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the results of treatment of Graves' disease by synthetic antithyroid drugs].
Fischer D; Poncin J; Dunet R; Dry J; Thomas M
Sem Hop; 1977 Oct 9-16; 53(34-35):1843-9. PubMed ID: 73224
[TBL] [Abstract][Full Text] [Related]
20. Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.
Walter MA; Schindler C; Christ-Crain M; Müller-Brand J; Müller B
Eur J Clin Invest; 2009 Jan; 39(1):51-7. PubMed ID: 19087129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
